Professional
Added to YB: 2024-02-21
Pitch date: 2024-02-20
MDT [bullish]
Medtronic plc
+20.3%
current return
Author Info
No bio for this author
Company Info
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally.
Market Cap
$126.3B
Pitch Price
$81.11
Price Target
112.00 (+15%)
Dividend
2.88%
EV/EBITDA
14.90
P/E
27.51
EV/Sales
4.15
Sector
Health Care Equipment and Supplies
Category
value
Medtronic plc: Pockets of Strength Supported Solid Growth in Fiscal Third Quarter
MDT: Strong Q3 despite US slowdown; 5% sales growth led by structural heart, spine, diabetes. Simplera Sync launch in Europe to rival Dexcom. Intl markets drove 8% net income gain. Wide moat from assets, switching costs, market share. Spin-offs may affect valuation; $112 FVE. Smart capital allocation balances M&A and dividends.
Read full article (9 min)